©The Author(s) 2026.
World J Diabetes. Feb 15, 2026; 17(2): 112859
Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.112859
Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.112859
Figure 2 Differences in bile acid levels among the healthy control, type 2 diabetes mellitus, and diabetic gastric autonomic neuropathy groups.
A: Cholic acid; B: Deoxycholic acid; C: Chenodeoxycholic acid; D: Ursodeoxycholic acid; E: Lithocholic acid; F: Glycocholic acid; G: Glycodeoxycholic acid; H: Glycochenodeoxycholic acid; I: Glycoursodeoxycholic acid; J: Glycolithocholic acid; K: Taurocholic acid; L: Taurodeoxycholic acid; M: Taurochenodeoxycholic acid; N: Tauroursodeoxycholic acid; O: Taurolithocholic acid. Data are presented as the median (interquartile range), and significant difference was assessed using Wilcoxon’s rank sum test. aP < 0.05; bP < 0.01. T2DM: Type 2 diabetes mellitus; HC: Healthy control; DGAN: Diabetic gastric autonomic neuropathy; CA: Cholic acid; DCA: Deoxycholic acid; CDCA: Chenodeoxycholic acid; UDCA: Ursodeoxycholic acid; LCA: Lithocholic acid; GCA: Glycocholic acid; GDCA: Glycodeoxycholic acid; GCDCA: Glycochenodeoxycholic acid; GUDCA: Glycoursodeoxycholic acid; GLCA: Glycolithocholic acid; TCA: Taurocholic acid; TDCA: Taurodeoxycholic acid; TCDCA: Taurochenodeoxycholic acid; TUDCA: Tauroursodeoxycholic acid; TLCA: Taurolithocholic acid.
- Citation: Zhu KY, Wang SJ, Li J, Ma PP, Feng SS, Guo L, Lu YB, Dong L, Ding DF. Association of serum bile acid profiles with the risk of gastrointestinal autonomic neuropathy in patients with type 2 diabetes mellitus. World J Diabetes 2026; 17(2): 112859
- URL: https://www.wjgnet.com/1948-9358/full/v17/i2/112859.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i2.112859